Solid tumor
Conditions
Interventions
control group:conventional treatment
observational group: Conventional treatment combined with Qingfei Decoction
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with solid tumors by histopathology; 2. Common respiratory viral infections confirmed by pathogen or antigen testing (respiratory syncytial virus adenovirus coronavirus influenza virus Epstein-Barr virus parainfluenza virus human metapneumovirus cytomegalovirus rhinovirus measles virus coxsackievirus etc.); 3. Presence of obvious respiratory symptoms cough severity score (CET = 8 points).
Exclusion criteria
Exclusion criteria: 1. Those allergic to the components of the Qingfei Heji; 2. Those with a history of chronic lung diseases (including bronchiectasis asthma chronic obstructive pulmonary disease chronic cough for more than 8 weeks lung cancer lung abscess respiratory bacterial infections etc.); 3. Current or former heavy smokers defined as a smoking index (number of smoking years multiplied by the number of cigarettes smoked per day) = 400; 4. Those unable to complete regular follow-ups; 5. Those with severe comorbidities or acute exacerbations of chronic diseases (such as acute heart failure); 6. Subjects who participated in or are currently participating in other clinical trials within one month prior to this study; 7. Those taking other traditional Chinese medicine during the study period.period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough Examination Test(CET); | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of dyspnea (Revised British Medical Research Council dyspnea questionnaire);Pulmonary fibrosis assessment;Fatigue level rating; | — |
Countries
China
Contacts
Public ContactZhang Aiqin
Zhejiang Cancer Hospital
Outcome results
None listed